© 2023 MJH Life Sciences and Cannabis Science and Technology . All rights reserved.
© 2023 MJH Life Sciences™ , Cannabis Science and Technology . All rights reserved.
July 26, 2023
Mental Health Options, an advocacy group based in Massachusetts, has filed paperwork to list psychedelic decriminalization as a ballot question for voters.
July 04, 2023
The FDA issued first draft guidance on clinical trials with psychedelic drugs.
June 27, 2023
Toms Shoes founder promises $100 million towards psychedelic research and access.
April 18, 2023
A recent study of a psychedelic compound found in ayahuasca produced new brain scans showing its impacts on the brain.
February 09, 2023
Starting July 1, 2023, Australia will allow the use of psilocybin and 3,4-Methylenedioxymethamphetamine (MDMA) for therapeutic use in a medical setting to treat mental health conditions.
January 26, 2023
Results from recently published survey studies on the effect of psilocybin and bipolar disorder offered support for the design of future clinical trials.
September 28, 2022
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares his experience with older patients and women who are interested in medical cannabis or psychedelics.
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares what he hopes to see happen in the future for patients interested in medical cannabis and psychedelics.
September 27, 2022
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the most surprising results and quality of treatment response he sees when treating his patients with medical cannabis and psychedelics.
September 16, 2022
Dr. Dustin Sulak of Healer.com and Integr8 Health shares some insights from two talks he gave at Cannabis Science Conference East 2022.